India Environment Portal | News, reports, documents, blogs, data, analysis on environment & development | India, South Asia
Published on India Environment Portal | News, reports, documents, blogs, data, analysis on environment & development | India, South Asia (http://admin.indiaenvironmentportal.org.in)

Home > Featured Articles > A trial of Lopinavir–Ritonavir in adults hospitalized with severe Covid-19 > A trial of Lopinavir–Ritonavir in adults hospitalized with severe Covid-19

A trial of Lopinavir–Ritonavir in adults hospitalized with severe Covid-19 [1]

Researchers conducted a randomized, controlled, open-label trial involving hospitalized adult patients with confirmed SARS-CoV-2 infection, which causes the respiratory illness Covid-19, and an oxygen saturation (Sao2) of 94% or less while they were breathing ambient air or a ratio of the partial pressure of oxygen (Pao2) to the fraction of inspired oxygen (Fio2) of less than 300 mm Hg. [2] Patients were randomly assigned in a 1:1 ratio to receive either lopinavir–ritonavir (400 mg and 100 mg, respectively) twice a day for 14 days, in addition to standard care, or standard care alone. The primary end point was the time to clinical improvement, defined as the time from randomization to either an improvement of two points on a seven-category ordinal scale or discharge from the hospital, whichever came first.

Original Source [3]

Publication Date: 
18/03/2020
Bin Cao [4], Yeming Wang [5], Danning Wen & et al [6]
New England Journal of Medicine [7]
1-13
Tags:
Coronavirus [8], Drugs [9], Medical Research [10], Respiratory Diseases [11], China [12]
Centre for Science and Environment
National Knowledge Commission Government of India

Technology Partners: MimirTech


India Environment Portal by Centre for Science and Environment is licensed under a Creative Commons Attribution-Share Alike 2.5 India License.


Source URL: http://admin.indiaenvironmentportal.org.in/feature-article/trial-lopinavir%E2%80%93ritonavir-adults-hospitalized-severe-covid-19

Links:
[1] http://admin.indiaenvironmentportal.org.in/feature-article/trial-lopinavir%E2%80%93ritonavir-adults-hospitalized-severe-covid-19
[2] http://www.indiaenvironmentportal.org.in/files/file/Lopinavir-Ritonavir-Covid-19.pdf
[3] https://www.nejm.org/doi/full/10.1056/NEJMoa2001282
[4] http://admin.indiaenvironmentportal.org.in/category/author/bin-cao
[5] http://admin.indiaenvironmentportal.org.in/category/author/yeming-wang
[6] http://admin.indiaenvironmentportal.org.in/category/author/danning-wen-et-al
[7] http://admin.indiaenvironmentportal.org.in/category/journal/new-england-journal-medicine
[8] http://admin.indiaenvironmentportal.org.in/category/thesaurus/coronavirus
[9] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drugs
[10] http://admin.indiaenvironmentportal.org.in/category/thesaurus/medical-research
[11] http://admin.indiaenvironmentportal.org.in/category/thesaurus/respiratory-diseases
[12] http://admin.indiaenvironmentportal.org.in/category/thesaurus/china